ANTICORPS ANTI-CLAUDINE 18.2 ET LEURS UTILISATIONS

• 收藏
• 分享

专利权人:

LANOVA MEDICINES LIMITED COMPANY

发明人:

LI, RUNSHENG

申请号：

CA3090726

公开号：

CA3090726A1

申请日:

2019.05.20

申请国别(地区):

CA

年份:

2019

代理人:

摘要：

Provided are antibodies or fragment thereof having binding specificity to the wild-type human claudin 18.2 (CLDN18.2) protein and also capable of binding the M149L mutant. By contrast, such antibodies and fragments do not or weakly bind to claudin 18.1 (CLDN18.1).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/